… factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the …

P Wimberger, N Lehmann, R Kimmig, A Burges… - Gynecologic …, 2007 - Elsevier
… a performance status according to Eastern Cooperative Oncology Group performance status
(ECOG) of 0–2 were enrolled in this multi-center prospective randomized phase III study in …

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - Journal of clinical …, 2012 - ascopubs.org
… Median age of all patients was 61.8 years, and 72% had an ECOG performance status of 0.
The percentage of males was significantly greater in the surgery alone arm (89% v 78%; P = .…

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients …

M Peeters, TJ Price, A Cervantes… - Journal of clinical …, 2010 - ascopubs.org
… Patients with mCRC, one prior chemotherapy regimen for mCRC, Eastern Cooperative
Oncology Group performance status 0 to 2, and available tumor tissue for biomarker testing were …

[HTML][HTML] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients …

SH Park, DH Lim, TS Sohn, J Lee, DY Zang, ST Kim… - Annals of …, 2021 - Elsevier
… Eastern Cooperative Oncology Group (ECOG) performance status scores range from 0 to
5, with higher scores indicating greater disability. A score of 0 indicates no symptoms, and 1 …

Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell carcinoma of the urothelium

DL Trump, P Elson, S Madajewicz, SH Dickman… - The Journal of …, 1990 - Elsevier
Randomization. To balance potential risk factors between the 2 treatments patients were
randomized … measurable versus evaluable disease, and performance status 0 or 1 versus 2 or 3…

Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma

ML Rothenberg, B LaFleur, DE Levy… - Journal of Clinical …, 2005 - ascopubs.org
performance status, and tumor measurement were performed within 4 weeks before
randomization. … (CEA) were obtained within 2 weeks of randomization. CBC, serum chemistry, and …

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

AP Chahinian, K Antman, M Goutsou… - Journal of clinical …, 1993 - ascopubs.org
… a performance status of 0 to 2 by CALGB criteria, and no prior chemotherapy. Central pathology
review was performed. Randomization … Good performance status (0 or 1) was associated …

[HTML][HTML] … ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase …

RJ Van Soest, AJ Templeton, FE Vera-Badillo… - Annals of …, 2015 - Elsevier
… Associations of dNLR and duration of initial ADT with overall survival (OS) were evaluated
by multivariable Cox regression analysis in the training set stratified for performance status

One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial

AK Singh, JA Gomez-Suescun, KL Stephans… - International Journal of …, 2019 - Elsevier
… This randomized phase 2 study demonstrated that 30 Gy in 1 fraction was equivalent to 60
… aged 18 years or older with a Zubrod performance status score of 0 to 2, deemed medically …

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell …

MB Atkins, M Hidalgo, WM Stadler, TF Logan… - Journal of clinical …, 2004 - ascopubs.org
… IFN-α treatment were Karnofsky performance status less than 80%, … The patients in this
CCI-779 phase II study were … of 1, rather than Karnofsky performance status less than 80%, and …